Skip to main content
← All data ties

Research And Development In The Physical, Engineering, And Life Sciences (Except Biotechnology) federal obligations in FY2026

$112,423,161.05 is the USAspending.gov FY2026 obligation total for Research And Development In The Physical, Engineering, And Life Sciences (Except Biotechnology) (NAICS 541712). Under one-tenth of one percent of a 145.6-billion-dollar R&D extract is an early FY2026 slice. Eight thousand twenty-two industry-extract awards describe a huge parent book that this yearlyTrend cell barely samples. That pair is Research And Development In The Physical, Engineering, And Life Sciences (Except Biotechnology) (NAICS 541712) and federal fiscal year 2026 — not every federal dollar in FY2026, not Research And Development In The Physical, Engineering, And Life Sciences (Except Biotechnology)'s $145,644,197,179.80 extract-wide book, and not cash already paid. The cell is 0.1% of this industry's published obligation total. 8,022 is the industry-extract award-record count, not a FY2026-only instrument tally. USAspending.gov is the source. Correlation is not causation.

Key figures

  • Physical/Life Sci R&D (ex Biotech) in FY2026: $112,423,161.05 in USAspending obligations (NAICS 541712).
  • That cell is 0.1% of the industry's $145,644,197,179.80 extract-wide total.
  • 8,022 is the industry-extract award-record count, not a FY2026 census.
  • NAICS 541712 × FY2026 is an obligation join, not an outlay and not a named-recipient list.
  • Cite USAspending.gov; quote /industries/541712/ and /fiscal-years/2026/ if live tables moved.

How 541712 meets fiscal year 2026 in the award file

NAICS 541712 and fiscal year 2026 meet here. $112,423,161.05 is the USAspending.gov obligation sum on the yearlyTrend row that carries both tags. It is not Research And Development In The Physical, Engineering, And Life Sciences (Except Biotechnology)'s nationwide all-year total of $145,644,197,179.80, not every federal dollar coded to FY2026, and not an outlay register. The packet does not split physical from engineering from life-science lines, and it excludes biotechnology by NAICS definition. 8,022 is an industry-extract action count: modifications and repeat awards add rows across years. Unique recipients are unpublished. This cell is not a lab census, a named-PI roster, or a publication log.

Open /industries/541712/ (NAICS 541712) for the industry table without this FY2026 filter, /fiscal-years/2026/ (FY2026 federal spending) for the year table without this NAICS filter, /industries/ (All industries) for every industry, and /ties/ (All spending ties) for the rest of the join list. Quote those hubs as parents, not as addends to $112,423,161.05. Physical/life-science R&D except biotechnology (541712) is not social-sciences-and-humanities R&D (541720).

Keeping 541712 from collapsing into a nearby NAICS

USAspending labels NAICS 541712 as Research And Development In The Physical, Engineering, And Life Sciences (Except Biotechnology). That code produced $112,423,161.05 when crossed with fiscal year 2026. The industry-wide 541712 hub does not require a FY2026 filter. The year hub does not require Physical/Life Sci R&D (ex Biotech). Only this tie applies both filters. The packet does not split physical from engineering from life-science lines, and it excludes biotechnology by NAICS definition. Do not forecast the rest of FY2026 from this snapshot. Biotechnology is excluded by the NAICS label as written.

Correlation is not causation: FY2026 did not cause $112,423,161.05 by existing as a large or small budget year. The join is 541712 × FY2026 only. This cell is not a lab census, a named-PI roster, or a publication log. Do not invent contractors or award recipients to fill the gap. Campaign donations on FEC tables do not fund this USAspending cell; the datasets are separate. 8,022 is the 541712 extract award-record count across years, not a FY2026 lab census or a named-PI roster.

8,022 is not a FY2026 vendor list

8,022 is the Research And Development In The Physical, Engineering, And Life Sciences (Except Biotechnology) award-record count published with the industry extract, not a count of FY2026 instruments. Dividing $112,423,161.05 by 8,022 would mix a one-year dollar total with a multi-year row count, so this page does not publish that ratio as a typical invoice. Unique recipients are unpublished. Modifications and multi-year vehicles can add lines without adding vendors. 8,022 is the 541712 extract award-record count across years, not a FY2026 lab census or a named-PI roster. FY2026 figures can be incomplete for the current year, so even the dollar cell may still move.

A thick parent file makes a program split tempting; the packet still does not supply one. A thin parent file makes a named-facility story tempting; the packet still does not name facilities or contractors. 0.1% of $145,644,197,179.80 is the year share on this packet, not a performance score.

$112,423,161.05 is a commitment sum

USAspending.gov records an obligation when the federal government commits funds on an award. $112,423,161.05 is that kind of sum for Research And Development In The Physical, Engineering, And Life Sciences (Except Biotechnology) in FY2026. Later deobligations, recoveries, or payment schedules can change what leaves the Treasury without this join rewriting itself into a cash register. Assistance and contract awards can share the same NAICS rollup; this packet does not split them. Net obligations can include downward adjustments. This page reports $112,423,161.05 as given.

Treat 8,022 as award records on the industry extract, not unique vendors and not a FY2026 headcount. Do not per-capita or per-recipient the dollar total; those denominators are unpublished. FEC contribution tables do not fund these awards. Lab names and publication counts are unpublished. Quote 541712 and FY2026 together.

Using /industries/541712/ and /fiscal-years/2026/ as overlays

Cite USAspending.gov: Research And Development In The Physical, Engineering, And Life Sciences (Except Biotechnology) (NAICS 541712) obligated $112,423,161.05 in FY2026. Name Research And Development In The Physical, Engineering, And Life Sciences (Except Biotechnology) and FY2026 together. Keep the obligation word. If /industries/541712/ or /fiscal-years/2026/ has refreshed, prefer the live hub over this snapshot for current rows. The pair is not a lab census, a named-PI roster, or a publication log. 0.1% of $145,644,197,179.80 is the industry share on this packet, not a budget score. /industries/ lists other industries; /ties/ indexes other pairs.

Keep Research And Development In The Physical, Engineering, And Life Sciences (Except Biotechnology), FY2026, $112,423,161.05, and the 8,022-record industry extract together without mixing clocks. Do not add those parents to this cell. Sharing a year with Physical/Life Sci R&D (ex Biotech) does not mean campaign donations funded these awards, and it does not convert obligations into outlays. This page reports one USAspending yearlyTrend join. Physical/life-science R&D except biotechnology (541712) is not social-sciences-and-humanities R&D (541720).

How not to reuse $112,423,161.05

8,022 is the 541712 extract award-record count across years, not a FY2026 lab census or a named-PI roster. Physical/life-science R&D except biotechnology (541712) is not social-sciences-and-humanities R&D (541720). A reader who quotes 8,022 as unique companies in FY2026 has left the packet. A reader who treats 0.1% as a hardship or success ranking has added a score the table does not carry. Prefer /industries/541712/ and /fiscal-years/2026/ if the live tables moved. Lab names and publication counts are unpublished. Quote 541712 and FY2026 together.

This snapshot holds $112,423,161.05 on the yearlyTrend row and 8,022 on the industry extract. /ties/ is the index, not an addend. Obligations are not outlays. Correlation is not causation. A reader who only quotes $112,423,161.05 without FY2026 and NAICS 541712 has dropped a join side.

Questions

How much Physical/Life Sci R&D (ex Biotech) spending is obligated in FY2026?
USAspending.gov lists $112,423,161.05 in Research And Development In The Physical, Engineering, And Life Sciences (Except Biotechnology) (NAICS 541712) obligations for FY2026. That yearlyTrend amount is 0.1% of the industry's $145,644,197,179.80 extract-wide total. It is an obligation join, not an outlay and not every federal dollar in FY2026. Unique recipients are unpublished.
Is $112,423,161.05 the entire Physical/Life Sci R&D (ex Biotech) USAspending total?
No. NAICS 541712's extract-wide total is $145,644,197,179.80. FY2026 is 0.1% of that book. Other fiscal-year rows for the same industry are separate cells. Do not add /industries/541712/ into this join. 8,022 award records stay on the industry extract, not on this yearlyTrend row.
Is $112,423,161.05 cash already paid in FY2026?
No. Obligations are commitments recorded on USAspending.gov awards. Outlays — money that actually left the Treasury — are a different concept and are not this packet's headline. Treating $112,423,161.05 as checks already cleared in FY2026 confuses those terms. Prefer the live industry and year hubs if the tables moved.
Does 8,022 awards mean 8,022 unique companies in FY2026?
No. 8,022 is the industry-extract award-record count for Research And Development In The Physical, Engineering, And Life Sciences (Except Biotechnology), not unique vendors and not a FY2026 headcount. Modifications add rows. This packet names no contractors. Keep the extract count off the yearlyTrend clock.

USAspending.gov NAICS yearlyTrend by fiscal year. Obligations are not outlays. FY figures can be incomplete for the current year.